| Literature DB >> 24396421 |
Qinkai Chen1, Feng He1, Xiaoran Feng2, Zhengmao Luo3, Jianlin Zhang3, Li Zhang1, Yu Wang1, Junrong Tong3.
Abstract
Ultrasound examination is a non-invasive diagnostic technique that is used on patients with suspected or established renal disease. The purpose of this study was to determine the role of intrarenal Doppler ultrasonography in the assessment of the renal pathology of patients with chronic kidney disease (CKD), as shown by kidney biopsy. This retrospective analysis enrolled 992 consecutive patients with CKD who underwent intrarenal Doppler ultrasonography and a kidney biopsy at the Departments of Nephrology of three hospitals between January 2006 and December 2010. Doppler parameters, including the peak systolic velocity (PSV), end-diastolic velocity and resistive index (RI) of the interlobar arteries, were compared with the renal biopsy findings. The RI of the interlobar arteries was correlated with the estimated glomerular filtration rate and the histological damage scores, demonstrating the most evident correlation with the tubulointerstitial damage (TI) score among the three histological components. The PSV of the interlobar arteries increased as the CKD stage progressed and correlated with a number of the renal histological changes, including the glomerulosclerosis and TI scores. The RI and PSV of the interlobar artery are correlated with the histopathological pattern in CKD. Thus, the RI and PSV of the interlobar artery may be potential indicators for monitoring the progression of renal damage.Entities:
Keywords: Doppler; end-diastolic velocity; peak systolic velocity; renal pathology; resistive index
Year: 2013 PMID: 24396421 PMCID: PMC3881055 DOI: 10.3892/etm.2013.1442
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Baseline characteristics of the participants (n=992).
| Variable | Value |
|---|---|
| Demographic | |
| Age (years; mean ± SD) | 63±11 |
| Male/female (n) | 605/387 |
| Body mass index (kg/m2) | 24.41±3.52 |
| Comorbidities | |
| Hypertension [n (%)] | 641 (64.6) |
| Systolic BP (mmHg; mean ± SD) | 134.6±33.7 |
| Diastolic BP, (mmHg; mean ± SD) | 84.7±23.2 |
| Diabetes mellitus [n (%)] | 293 (29.5) |
| Cardiovascular disease [n (%)] | 281 (28.3) |
| Laboratory | |
| Hemoglobin (g/l; mean ± SD) | 97.5±23.5 |
| Serum creatinine (μmol/l; mean ± SD) | 221.4±62.6 |
| eGFR (ml/min/1.73 m2; mean ± SD) | 21.2±5.9 |
BP, blood pressure; eGFR, estimated glomerular filtration rate.
Figure 1Changes in the kidney size based on the CKD stages. The renal length was significantly smaller in the patients with stage 5 CKD compared with that in the patients with stage 1, 2 or 3 CKD (P<0.01). However, in patients with stages 1–3 CKD, no clear association between the disease stage and kidney size was identified. *P<0.05 versus stage 1, 2 or 3. CKD, chronic kidney disease.
Correlation coefficients (r) of the ultrasonographic parameters with the clinical and histological parameters (n=992).
| Renal parameters | Renal length | RI | PSV | EDV |
|---|---|---|---|---|
| Serum creatinine levels | −0.11 | 0.10 | 0.32 | 0.05 |
| eGFR | 0.29 | −0.31 | −0.03 | −0.07 |
| Glomerulosclerosis score | −0.27 | 0.28 | 0.64 | 0.10 |
| Tubulointerstitial damage score | −0.19 | 0.43 | 0.55 | 0.09 |
| CKD stage | −0.04 | 0.02 | 0.23 | 0.06 |
P<0.01,
P<0.05.
RI, resistive index; PSV, peak systolic velocity; EDV, end-diastolic velocity; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease.
Figure 2Changes in PSV based on the CKD stages. The PSV increased with CKD progression (P<0.01). *P<0.01 versus stage 1, #P<0.01 versus stage 2, &P<0.01 versus stage 3. CKD, chronic kidney disease; PSV, peak systolic velocity.